Penicillamine and Ventricular hypokinesia - a phase IV clinical study of FDA data

Summary:

No or too few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 24, 2023

No or too few reports are found.


What is Penicillamine?

Penicillamine has active ingredients of penicillamine. Currently, eHealthMe is studying from 1,299 Penicillamine users.

What is Ventricular Hypokinesia?

Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do) is found to be associated with 1,217 drugs and 660 conditions by eHealthMe. Currently, we are studying 4,159 people who have Ventricular hypokinesia.

Do you take Penicillamine and have Ventricular hypokinesia?

Check whether Ventricular hypokinesia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Ventricular hypokinesia and when was it recovered:

Expand to all the drugs that have ingredients of penicillamine:

Alternative drugs to, pros and cons of Penicillamine:

Browse all side effects of Penicillamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ventricular hypokinesia treatments and more:

All the drugs that are associated with Ventricular hypokinesia:

All the conditions that are associated with Ventricular hypokinesia:

How the study uses the data?

The study uses data from the FDA. It is based on penicillamine (the active ingredients of Penicillamine) and Penicillamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: